Satellos Bioscience Inc. (MSLE) Live Share Price, Invest From India

Satellos Bioscience Inc. Stock Performance

as on July 3, 2026 at 6:59 am IST

Day's Low
Day's High
$7.21
Day's Price Range
$7.63
$7.23
0.28%
Downside
5.53%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$7.23
100.00%
Downside
-100.00%
Upside

Satellos Bioscience Inc. share price movements today

Previous Close: $7.58
Open: $7.60
Volume: 249.9K
Day's Low - High: $7.21 - $7.63

Satellos Bioscience Inc. Historical Returns

1 Month Return: + 9.06 %
3 Month Return: + 29.13 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Satellos Bioscience Inc. Stock Fundamentals & Key Indicators

Check Satellos Bioscience Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$161.4M

EPS (TTM)

-2.64

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-50.74%

Satellos Bioscience Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Satellos Bioscience Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Satellos Bioscience Inc.	NA	$161.4M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$39.8B	472.9%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$40.2B	75.97%	75.83	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$126.1B	148.33%	29.5	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	7.04%	15.22	29.65%	0.5700000000000001%

Indian Investors' Interest in Satellos Bioscience Inc. Stock

Search interest for Satellos Bioscience Inc. Stock has increased by 222% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 3, 2026 to July 3, 2026

Change:222% versus previous 30 day period

Satellos Bioscience Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-5	-4	-6	-6	-5	-7	-10
EBITDA	-5	-3	-6	-6	-5	-7	-10
Interest Expense	-	-	-	-	-	-	-
Depreciation	0	0	0	-	0	-	0
Income Before Tax	-8	-3	-6	-5	-5	-7	-9
Income Tax Expense	-	-	0	0	0	0	0
Net Income	-8	-2	-6	-5	-5	-7	-9
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Satellos Bioscience Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-
Gross Profit	0	0	0	0	0
Operating Income	-3	-6	-11	-19	-26
EBITDA	-11	-10	-11	-19	-26
Interest Expense	0	-	0	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-12	-8	-11	-19	-24
Income Tax Expense	0	0	-	-	0
Net Income	-9	-11	-8	-13	-24
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Satellos Bioscience Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-5	-4	-8	-3	-6	-5	-5	-7	-9
Operating Cash Flow	-5	-4	-4	-7	-7	-4	-4	-7	-9
Investing Cash Flow	-1	1	17	-11	-	8	-15	-2	-32
Financing Cash Flow	-	0	0	53	0	1	0	0	51
Change in Cash	-6	-2	13	22	-7	5	-18	-9	8

Satellos Bioscience Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	-1	-1	-1	-12	-11	-15	-19	-24
Operating Cash Flow	0	0	-1	-1	-3	-5	-14	-17	-23
Investing Cash Flow	0	0	0	-	1	0	-13	4	-9
Financing Cash Flow	-	-	2	1	5	2	50	37	2
Change in Cash	0	0	0	0	3	-1	15	24	-30

Global Institutional Holdings in Satellos Bioscience Inc.

Funds	Holdings
Siren, L.L.C.	4.28%
Suvretta Capital Management, LLC	2.28%
Adage Capital Partners Gp LLC	1.83%
Royal Bank of Canada	0.08%
Millennium Management LLC	1.43%

See all

Insights on Satellos Bioscience Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, MSLE stock has moved up by 13.0%

About Satellos Bioscience Inc.

Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Organisation	Satellos Bioscience Inc.
Headquarters	Royal Bank Plaza, Toronto, ON, Canada, M5J 2J1
Industry	Biotechnology
CEO	Mr. Francis Gleeson B.B.A. M.B.A
E-voting on shares	Click here to vote

Key Management of Satellos Bioscience Inc.

Name	Title
Ms. Elizabeth Williams C.A., CPA	CFO & Corporate Secretary
Mr. J. Robert Hall CFA	Senior Vice President of Finance & Administration
Ms. Desiree Chan	Chief of Staff
Mr. Francis Gleeson B.B.A. M.B.A	Co-Founder, CEO, President & Director
Dr. Wildon Farwell M.D., M.P.H.	Chief Medical Officer
Dr. Michael A. Rudnicki Ph.D.	Co-Founder & Chief Discovery Officer
Dr. Ryan Mitchell Ph.D.	Senior VP & Head of Corporate Development
Mr. Michael Liggett B.Sc., Bsc. Pharm., C.A., C.P.A.	Strategic Advisor
Ms. Antoinette Paone M.B.A., M.S.	Chief Development Officer & Head of Regulatory Affairs
Dr. Philip Lambert M.A., Ph.D.	Chief Scientific Officer

FAQs

What is Satellos Bioscience Inc. share price today?

Satellos Bioscience Inc. share price today is $7.23 as on July 3, 2026 at 1:29 am IST at the close of the market. Satellos Bioscience Inc. share today touched a day high of $7.63 and a low of $7.21.

What is the 52 week high and 52 week low for Satellos Bioscience Inc. share?

Satellos Bioscience Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Satellos Bioscience Inc. stock price today i.e. July 3, 2026 at 1:29 am IST is closed at $7.23,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Satellos Bioscience Inc.'s market capitalisation today?

Satellos Bioscience Inc. market capitalisation is $0.00T as on July 3, 2026 at 1:29 am IST.

How to invest in Satellos Bioscience Inc. Stock (MSLE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Satellos Bioscience Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Satellos Bioscience Inc. Shares that will get you 0.2075 shares as per Satellos Bioscience Inc. share price of $7.23 per share as on July 3, 2026 at 1:29 am IST.

What is the minimum amount required to buy Satellos Bioscience Inc. Stock (MSLE) from India?

Indian investors can start investing in Satellos Bioscience Inc. (MSLE) shares with as little as ₹95.39 or $1 (as of July 3, 2026 at 5:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.90 in Satellos Bioscience Inc. stock (as per the Rupee-Dollar exchange rate as on July 3, 2026 at 5:40 am IST). Based on Satellos Bioscience Inc. share’s latest price of $7.23 as on July 3, 2026 at 1:29 am IST, you will get 1.3831 shares of Satellos Bioscience Inc.. Learn more about fractional shares .